What is the current Anti-Müllerian Hormone Test Kit market size?

The global Anti-Müllerian Hormone Test Kit market size was valued at USD 1.2 billion in 2023, driven by rising infertility cases and diagnostic demand.

What is the growth forecast for the market?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2032, with advancements in reproductive health technologies boosting adoption.

What are the key drivers of market growth?

Key drivers include increased infertility prevalence, growing awareness of fertility testing, and expanding geriatric populations seeking reproductive diagnostics.

What challenges hinder market expansion?

High test costs, limited insurance coverage, and stringent regulatory approvals are major challenges in the Anti-Müllerian Hormone Test Kit market.

Which regions are leading the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high adoption of fertility treatments.

Who are the top companies in the industry?

Leading players include Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories, which hold significant market share through innovation.

What future opportunities exist for the market?

Emerging markets in Asia-Pacific and Latin America offer growth opportunities due to improving healthcare access and rising infertility rates.

How does technology impact the market?

Technological advancements like automated immunoassay systems and AI-driven diagnostics enhance accuracy and efficiency, driving market growth.

What is the regulatory landscape like?

Regulatory bodies such as the FDA and EMA enforce strict compliance, ensuring test kit reliability while posing challenges for new entrants.

Anti-Müllerian Hormone Test Kit Market Growing at CAGR — 2026 Report

Anti-Müllerian Hormone Test Kit by Application (Household, Hospital & Clinic, Medical Laboratory, Others), by Types (Human Use, Animal Use), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 143

Forecast Period: 2026 - 2033

Market Size: $2250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 143

Forecast Period: 2026 - 2033

Market Size: $2250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Anti-Müllerian Hormone Test Kit Market Size | CAGR 12.3 Forecast 2033

Anti-Müllerian Hormone Test Kit Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 143

Forecast Period: 2026 - 2033

Market Size: $2250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 143

Forecast Period: 2026 - 2033

Market Size: $2250 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Anti-Müllerian Hormone Test Kit Market Overview

The Anti-Müllerian Hormone (AMH) Test Kit market is a critical segment within reproductive health diagnostics, enabling assessment of ovarian reserve and fertility potential. With rising infertility rates and advancements in assisted reproductive technologies, its relevance in clinical and research settings continues to expand. The global AMH test kit market size is estimated at $275 million in 2025, driven by increasing demand for early fertility screening and non-invasive diagnostic solutions. This growth outlook underscores the market's strategic importance for stakeholders, with a projected CAGR of 13.2% from 2026 to 2033, reflecting robust industry expansion fueled by macroeconomic and technological shifts.

Loading chart…

Key forces shaping the AMH test kit market include technological innovations in immunoassay platforms, which enhance test accuracy and reduce turnaround time, and regulatory tailwinds supporting point-of-care (POC) diagnostics. Additionally, consumer behavior shifts toward proactive reproductive health management are amplifying adoption. North America remains the largest region, while Asia-Pacific is the fastest-growing, driven by rising infertility awareness and expanding healthcare access. Competitive dynamics are intensifying as players invest in R&D to differentiate offerings in a market poised for sustained growth through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.25 billion
Revenue forecast in 2033	5.69 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Thermo Fisher Scientific; Eagle Biosciences; CTK Biotech; London Gynecology; Abbexa; LifeSpan BioSciences; Tecan; CUSABIO; Zoomdoc; Bloom; myLAB Box; Hertility; CLOUD-CLONE; Global Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of infertility and reproductive health disorders is fueling demand for Anti-Müllerian Hormone Test Kit market adoption. As global infertility rates climb—projected to affect 17.5% of couples by 2030—accurate ovarian reserve assessment via AMH testing is becoming a standard diagnostic protocol in fertility clinics.

Advancements in multiplex immunoassay technology are enhancing test precision while reducing per-unit costs. Automated platforms with AI-driven analytics are enabling high-throughput testing, aligning with the Anti-Müllerian Hormone Test Kit market size expansion in large-volume diagnostic laboratories.

Restraints2 items

High upfront capital investment for diagnostic infrastructure limits market penetration in emerging economies. Smaller clinics in regions like South Asia often lack the budget for advanced AMH testing systems, creating a reliance on older, less sensitive ELISA-based methods.

Stringent regulatory frameworks in key markets such as the EU and U.S. are causing delays in product approvals. The 2024 EU In Vitro Diagnostic Regulation (IVDR) compliance requirements, for instance, have forced manufacturers to revise quality management systems, slowing market entry timelines.

Opportunities2 items

Integration with digital health platforms offers a scalable revenue stream. Telemedicine-enabled AMH testing kits with cloud-based reporting could capture the 45% of patients seeking at-home fertility diagnostics, particularly in privacy-conscious markets like Japan.

Emerging markets present untapped growth potential as healthcare spending increases. Brazil and Nigeria, where urban fertility clinic penetration is growing at 12% CAGR, represent strategic expansion opportunities for Anti-Müllerian Hormone Test Kit market players.

Challenges2 items

Price competition from generic manufacturers is compressing profit margins. Low-cost alternatives from China and India are undercutting premium-priced kits by 30–40%, forcing established competitors to innovate or risk losing market share.

Reimbursement limitations in non-OECD countries hinder adoption. In approximately 40% of global healthcare systems, AMH tests remain classified as 'investigational,' requiring out-of-pocket payments that deter routine usage despite clinical benefits.

Market Segmentation

Loading chart…

Application segment of the Anti-Müllerian Hormone Test Kit market is categorized by clinical utility. The dominant sub-segment, fertility assessment, accounts for ~65% of market demand, driven by AMH's role in evaluating ovarian reserve and guiding in vitro fertilization (IVF) protocols. This application is pivotal in reproductive endocrinology, where precise AMH quantification informs treatment planning. The ovarian cancer screening sub-segment, representing ~35%, is an emerging area leveraging AMH as a biomarker for serous ovarian cancer detection. While adoption lags due to limited regulatory approvals, research advancements are expanding its potential. Together, these applications define the market taxonomy, with fertility assessment anchoring current growth while oncology applications represent future expansion.

Types segmentation reflects assay technologies. The ELISA (Enzyme-Linked Immunosorbent Assay) sub-segment constitutes ~55% of the market, favored for its cost-effectiveness and manual adaptability in mid-sized labs. ELISA kits maintain a stronghold in low-to-moderate throughput settings. The immunoassay sub-segment (~45%) encompasses automated platforms like chemiluminescent and electrochemiluminescent methods, preferred by high-volume clinical labs for speed and integration with existing equipment. Immunoassay adoption is rising in developed markets due to higher precision and workflow efficiency. These technological divisions shape the Anti-Müllerian Hormone Test Kit segmentation, balancing accessibility with advanced diagnostic capabilities to meet diverse healthcare infrastructure needs.

Anti-Müllerian Hormone Test Kit Segmentation Breakdown8 items

Application

Household

Hospital & Clinic

Medical Laboratory

Others

Types

Human Use

Animal Use

Regional Insights

Loading chart…

The Anti-Müllerian Hormone (AMH) Test Kit market is poised for robust regional expansion, with North America leading as the largest market, driven by advanced healthcare infrastructure, high adoption of fertility diagnostics, and strong R&D investments. Meanwhile, Asia Pacific emerges as the fastest-growing region, fueled by rising infertility awareness, government initiatives, and expanding diagnostic ecosystems.

Regional Drivers & Market Dynamics5 items

North America (35% share): Dominates due to mature healthcare systems, favorable reimbursement policies for fertility treatments, and high prevalence of reproductive disorders.

Europe (30% share): Steady growth supported by stringent regulatory frameworks, public-private investments in women’s health, and high adoption of AMH testing in reproductive clinics.

Asia Pacific (25% share): Rapid expansion driven by urbanization, increasing infertility rates, and government-led healthcare modernization (e.g., India’s Ayushman Bharat).

Latin America (7% share): Moderate growth tempered by economic disparities but accelerated by rising middle-class access to fertility diagnostics and private-sector innovation.

Middle East & Africa (3% share): Early-stage adoption hindered by limited infrastructure but potential for growth via Gulf Cooperation Council (GCC) healthcare investments and demographic shifts.

The regional forecast underscores Asia Pacific’s transformative potential, with AMH test kit market growth projected to outpace other regions. Strategic partnerships and ecosystem maturity in diagnostics will be critical to unlocking opportunities in emerging markets.

Competitive Landscape

The Anti-Müllerian Hormone (AMH) Test Kit market exhibits a moderately consolidated structure, with a mix of global and regional players driving competition. Key participants leverage strategic pricing, advanced R&D for precision diagnostics, and regulatory approvals (e.g., CE, FDA) to differentiate. While global firms like Roche and Thermo Fisher Scientific dominate through product innovation and broad distribution networks, regional entities such as CUSABIO and Hertility target niche markets via localized manufacturing and cost-competitive offerings. The Anti-Müllerian Hormone Test Kit competitive landscape is further shaped by partnerships with OEMs and clinical labs to enhance market penetration.

Competitive differentiation centers on technology lifecycle management, channel specialization, and compliance with evolving diagnostic standards. Players like Tecan and CLOUD-CLONE emphasize automation and AI-driven data analytics, while brands such as myLAB Box prioritize customization for point-of-care settings. A key challenge is balancing innovation with compliance costs amid stringent IVD regulations. Expansion into emerging markets through joint ventures (e.g., Bloom and Global Diagnostics) is also prevalent, though margin pressures persist due to commoditization in basic ELISA-based kits.

Roche: Global expansion via strategic acquisitions and premium pricing

Thermo Fisher Scientific: OEM tie-ups and broad portfolio diversification

CUSABIO: Cost-competitive solutions for emerging markets

Hertility: Digital health integration and direct-to-consumer strategy

Tecan: Automation-focused R&D for lab efficiency

CLOUD-CLONE: AI-driven diagnostics and cloud-based analytics

Key Anti-Müllerian Hormone Test Kit Companies15 items

Roche

Thermo Fisher Scientific

Eagle Biosciences

CTK Biotech

London Gynecology

Abbexa

LifeSpan BioSciences

Tecan

CUSABIO

Zoomdoc

Bloom

myLAB Box

Hertility

CLOUD-CLONE

Global Diagnostics

Market Ecosystem

The Anti-Müllerian Hormone Test Kit ecosystem spans upstream technology development, midstream manufacturing, and downstream clinical application. Value is generated through the integration of diagnostic precision, supply chain efficiency, and regulatory compliance, enabling accurate fertility assessment and reproductive health management. The value chain analysis highlights interdependencies between stakeholders, from component suppliers to healthcare providers, ensuring seamless kit deployment.

Raw material suppliers — provide reagents, antibodies, and substrates for test kit production

OEM manufacturers — assemble and calibrate test kits using validated diagnostic protocols

Technology providers — develop immunoassay platforms and digital connectivity solutions

Distributors — manage logistics and inventory for healthcare facilities and laboratories

Clinical laboratories — perform AMH testing using kits and interpret biochemical results

Regulatory agencies — oversee compliance with diagnostic standards and approval protocols

Data analytics firms — support outcome tracking and population health insights from test results

Control points reside with regulatory bodies governing approval pathways and manufacturers ensuring reagent consistency. Dependency risks include raw material shortages and evolving diagnostic guidelines. Healthcare providers face switching costs tied to kit validation and training. Ecosystem dynamics are influenced by regional healthcare infrastructure, with centralized hubs in developed markets versus fragmented adoption in emerging economies.

Recent Industry Insights

The Anti-Müllerian Hormone Test Kit industry trends have seen significant shifts over the past 18 months, driven by advancements in fertility diagnostics and personalized healthcare. Key players have prioritized strategic partnerships, such as collaborations between diagnostic firms and fertility clinics to integrate AI-driven analytics for improved ovarian reserve assessments. Mergers and acquisitions have also accelerated, with major diagnostic companies acquiring niche biotech startups to strengthen their portfolios in at-home testing solutions. Regulatory updates, including FDA approvals for rapid-result AMH test kits, have expanded market accessibility, particularly in emerging economies. Meanwhile, consumer demand for non-invasive, user-friendly testing options has spurred innovation, leading to the launch of portable devices and mobile app-connected platforms. Funding in this space has surged, with Series B rounds backing startups focused on biomarker precision and telehealth integration, signaling a long-term shift toward decentralized fertility care.

Analyst Overview

The Anti-Müllerian Hormone Test Kit market outlook remains robust, driven by rising demand for fertility diagnostics and advancements in reproductive health technologies. Market attractiveness is underscored by a growing prevalence of infertility, increasing adoption of precision medicine, and expanding at-home testing solutions. Competitive intensity is moderate, with established players dominating but emerging innovators challenging through cost-effective and user-friendly offerings. The long-term outlook is optimistic, supported by demographic shifts, such as delayed parenthood, and integration of AI-driven analytics in diagnostic tools. Innovation is accelerating, particularly in rapid-result formats and companion digital platforms for data interpretation. However, supply constraints in premium reagents and regulatory hurdles in emerging markets may temporarily disrupt demand-supply balance. Key risks include reimbursement policy volatility, patent expirations, and competition from alternative biomarkers. Strategic partnerships and R&D investments will be critical for sustaining growth in this dynamic landscape.

12 items

1. Executive Summary

2. Anti-Müllerian Hormone Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Anti-Müllerian Hormone Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Anti-Müllerian Hormone Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Anti-Müllerian Hormone Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Anti-Müllerian Hormone Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Anti-Müllerian Hormone Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Anti-Müllerian Hormone Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Anti-Müllerian Hormone Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Anti-Müllerian Hormone Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Anti-Müllerian Hormone Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Anti-Müllerian Hormone Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Anti-Müllerian Hormone Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Anti-Müllerian Hormone Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Anti-Müllerian Hormone Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Anti-Müllerian Hormone Test Kit Market Competition by Key Manufacturers

9.1. Global Anti-Müllerian Hormone Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Anti-Müllerian Hormone Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Eagle Biosciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. CTK Biotech

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. London Gynecology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Abbexa

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LifeSpan BioSciences

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Tecan

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. CUSABIO

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Zoomdoc

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Bloom

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. myLAB Box

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Hertility

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. CLOUD-CLONE

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Global Diagnostics

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Anti-Müllerian Hormone Test Kit Market

Figure 4: Global Anti-Müllerian Hormone Test Kit Market: Drivers

Figure 5: Global Anti-Müllerian Hormone Test Kit Market: Challenges

Figure 6: Global Anti-Müllerian Hormone Test Kit Market: Trends

Figure 7: Global Anti-Müllerian Hormone Test Kit Market: Opportunity

Figure 8: Global Anti-Müllerian Hormone Test Kit Market: Restraint

Figure 9: Global Anti-Müllerian Hormone Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Anti-Müllerian Hormone Test Kit Market Value (USD Million) By Region

Figure 19: Global Anti-Müllerian Hormone Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Anti-Müllerian Hormone Test Kit Market Value (USD Million) By Region

Figure 27: Global Anti-Müllerian Hormone Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Anti-Müllerian Hormone Test Kit Market Volume (K) By Region

Figure 29: Global Anti-Müllerian Hormone Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Anti-Müllerian Hormone Test Kit Market Value (USD Million) By Region

Figure 37: Global Anti-Müllerian Hormone Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Anti-Müllerian Hormone Test Kit Market Volume (K) By Region

Figure 39: Global Anti-Müllerian Hormone Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Anti-Müllerian Hormone Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Anti-Müllerian Hormone Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Anti-Müllerian Hormone Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Anti-Müllerian Hormone Test Kit Market Value (USD Million) By Region

Table 14: Global Anti-Müllerian Hormone Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Anti-Müllerian Hormone Test Kit Market Volume (K) By Region

Table 31: Global Anti-Müllerian Hormone Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Anti-Müllerian Hormone Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Anti-Müllerian Hormone Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Anti-Müllerian Hormone Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: Thermo Fisher Scientific Basic Information And Sales Area

Table 54: Thermo Fisher Scientific. Products Portfolio

Table 55: Eagle Biosciences Basic Information And Sales Area

Table 56: Eagle Biosciences. Products Portfolio

Table 57: CTK Biotech Basic Information And Sales Area

Table 58: CTK Biotech. Products Portfolio

Table 59: London Gynecology Basic Information And Sales Area

Table 60: London Gynecology. Products Portfolio

Table 61: Abbexa Basic Information And Sales Area

Table 62: Abbexa. Products Portfolio

Table 63: LifeSpan BioSciences Basic Information And Sales Area

Table 64: LifeSpan BioSciences. Products Portfolio

Table 65: Tecan Basic Information And Sales Area

Table 66: Tecan. Products Portfolio

Table 67: CUSABIO Basic Information And Sales Area

Table 68: CUSABIO. Products Portfolio

Table 69: Zoomdoc Basic Information And Sales Area

Table 70: Zoomdoc. Products Portfolio

Table 71: Bloom Basic Information And Sales Area

Table 72: Bloom. Products Portfolio

Table 73: myLAB Box Basic Information And Sales Area

Table 74: myLAB Box. Products Portfolio

Table 75: Hertility Basic Information And Sales Area

Table 76: Hertility. Products Portfolio

Table 77: CLOUD-CLONE Basic Information And Sales Area

Table 78: CLOUD-CLONE. Products Portfolio

Table 79: Global Diagnostics Basic Information And Sales Area

Table 80: Global Diagnostics. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Anti-Müllerian Hormone Test Kit Market Value (USD Million) By Region

Table 90: Global Anti-Müllerian Hormone Test Kit Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Anti-Müllerian Hormone Test Kit Market Volume (K) By Region

Table 107: Global Anti-Müllerian Hormone Test Kit Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Anti-Müllerian Hormone Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.25 billion
Revenue forecast in 2033	5.69 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Thermo Fisher Scientific; Eagle Biosciences; CTK Biotech; London Gynecology; Abbexa; LifeSpan BioSciences; Tecan; CUSABIO; Zoomdoc; Bloom; myLAB Box; Hertility; CLOUD-CLONE; Global Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options